机译:Hematologic Malignancies: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner: The Advanced Practitioner Perspective: Ciltacabtagene Autoleucel, a BCMA-Directed CAR T-Cell Therapy, in Relapsed/Refractory Multiple Myeloma: Updated Results From CARTITUDE-1, By JADPRO Staff